Teboho Alfred Moerane

Department of Health Sciences, Debrecen University, Debrecen, Hungary

Publications

  • Review Article   
    A Review of Recurrent Meningiomas with Prolonged Response to Cabozantinib, an Oral Multitarget Tyrosine Kinase Inhibitor
    Author(s): Teboho Alfred Moerane62273* and Vuyiswa Kama62274

    Meningiomas are cerebral cancers that arise from abnormal cell development in the meninges and defensive layers covering the mind and spinal line. They can attack areas close to the cerebrum tissue and apply tension to neighboring designs, prompting different neurological side effects. Recent advances in atomic science and genomics have revealed insights into the fundamental sub-atomic adjustments and flagging pathways involved in the improvement of meningoma. Cabozantinib, a chemotherapeutic agent, has shown promising results in preclinical and clinical studies in various malignancies, including meningia. It inhibits angiogenesis, reduces cancer development, and prompts cell passage, providing areas of strength for clinical examination. Inhibition of VEGFR2 signaling has shown promise results in clinical trials in various cancer types, includ.. Read More»
    DOI: 10.31858/0975-8453.14.7.479-489

    Abstract HTML PDF